Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??
But the schedule 13G in Feb. (2/9) had them reporting 38 million in ownership. At the end of Feb., 29 million warrants were outstanding (10-Q), and at April 24th, 18 million were outstanding (April 24 PR). I'm not seeing where your numbers jive with what I'm seeing IMO. 23+8.5= 31.5 What am I missing?
Share
New Message
Please login to post a reply